As Senior Scientific Officer & Director, Research, Innovation, and Quality Assurance at Hayes, Petra Nass is responsible for product innovation and for ensuring the scientific and methodological quality of the Hayes evidence products.
Dr. Nass was a faculty member of the Johns Hopkins University and a postdoctoral fellow at the Food and Drug Administration. She developed plasmid vectors for gene therapy for herpes simplex virus and wound healing, and supported projects on molecular markers in esophageal cancer. This work resulted in peer-reviewed publications.
Dr. Nass has a broad understanding of research strategies and methods encompassing the natural and social sciences. Continuing education and certification in public policy and management (University of York, York, United Kingdom), cross-cultural training and management (Heidelberg University of Education, Heidelberg, Germany), systemic and integrative therapy (Psynapse School of Psychotherapy, Paris, France), and computational genomics and executive data science (Johns Hopkins University, Baltimore, USA) complement her professional experience. She has written and edited more than 100 health technology assessments or comparative effectiveness reviews.